Division of Cardiology, University Hospital S. Giovanni di Dio e Ruggi d'Aragona, Salerno, Italy.
Division of Cardiology, Garibaldi-Nesima Hospital, Catania, Italy.
J Cardiovasc Pharmacol Ther. 2021 Mar;26(2):149-157. doi: 10.1177/1074248420947633. Epub 2020 Aug 6.
There is an incomplete understanding of the prevalence and predictors of attainment of low-density lipoprotein cholesterol (LDL-C) goal after myocardial infarction (MI).
To evaluate the prevalence of achievement of LDL-C goal of 70 mg/dL, to identify the baseline features associated with suboptimal lipid control, and to assess the use of LDL-C-lowering drug therapies (LLT) beyond the first year after MI.
The EYESHOT Post-MI was a prospective, cross-sectional, Italian registry, which enrolled patients presenting to cardiologist 1 to 3 years after MI. In this retrospective post-hoc analysis, patients were categorized in 2 groups according to the achievement or not of the LDL-C goal of 70 mg/dL. Univariable and multivariable logistic regression analyses were performed to identify the baseline features associate with LDL-C≥70 mg/dL.
The study population included 903 patients (mean age 65.5 ± 11.5 years). Among them, LDL-C was ≥70 mg/dL in 474 (52.5%). Male sex ( = 0.031), hypertension ( = 0.024), prior percutaneous coronary intervention ( = 0.016) and high education level ( = 0.008) were higher in the LDL-C <70 group. At multivariable analysis, low education level was an independent predictor of LDL-C≥70 mg/dL (OR:1.582; 95%CI, 1.156-2.165; = 0.004). Conversely, hypertension increased the probability to achieve the LDL-C goal (OR:0.650; 95%CI, 0.443-0.954; = 0.028). Among off-target patients, LLT was not modified in the majority of cases (67.3%), intensified in 85 (18.6%), and actually reduced in 63 patients (13.8%).
In patients presenting to cardiologists 1 to 3 years from the last MI event, LDL-C is not under control in a large proportion of patients, particularly in those with a low education level or without hypertension. LLT is underused in this very-high-risk setting.
目前对于心肌梗死(MI)后低密度脂蛋白胆固醇(LDL-C)目标的达标率及其预测因素仍认识不全。
评估 LDL-C 目标值<70mg/dL 的达标率,明确与血脂控制不佳相关的基线特征,并评估 MI 后 1 年以上 LDL-C 降低药物治疗(LLT)的应用情况。
EYESHOT 后 MI 是一项前瞻性、横断面、意大利注册研究,共纳入 MI 后 1-3 年就诊于心脏病专家的患者。本回顾性事后分析中,根据 LDL-C 目标值<70mg/dL 的达成情况将患者分为两组。采用单变量和多变量逻辑回归分析确定与 LDL-C≥70mg/dL 相关的基线特征。
共纳入 903 例患者(平均年龄 65.5±11.5 岁),其中 474 例(52.5%)LDL-C 水平≥70mg/dL。LDL-C <70mg/dL 组中男性( = 0.031)、高血压( = 0.024)、既往经皮冠状动脉介入治疗( = 0.016)和高教育水平( = 0.008)的比例更高。多变量分析显示,低教育水平是 LDL-C≥70mg/dL 的独立预测因素(OR:1.582;95%CI:1.156-2.165; = 0.004)。相反,高血压可增加 LDL-C 目标达标率(OR:0.650;95%CI:0.443-0.954; = 0.028)。在未达标的患者中,大部分患者的 LLT 未进行调整(67.3%),85 例(18.6%)患者 LLT 强度增加,63 例(13.8%)患者实际减少 LLT。
在 MI 后 1-3 年就诊于心脏病专家的患者中,很大一部分患者的 LDL-C 控制不佳,特别是那些教育水平较低或无高血压的患者。在这种极高危患者中,LLT 的应用不足。